Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane debate and discuss the outcomes of the trials presented on day 3 at ACC.24 including TARGET BP I (0:39), DEDICATE DZHK6 (3:07) and FULL REVASC (6:31).

ACC.org will provide coverage of all the latebreaking science being presented at ACC.24 (https://accscientificsession.acc.org/) to help you find out how it all fits into your practice. For trial summaries, news coverage, daily video wrapups and more, visit ACC's Meeting Coverage Page (https://www.acc.org/LatestinCardiol.... Follow the ACC on Social Media (https://www.acc.org/AboutACC/Social...) and use the hashtag #ACC24 (  / acc24  ) to join the conversation.